PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 May 2026 12:00 PM
RNS
PRTC To Showcase Deupirfenidone at ATS Conference
08 May 2026 07:00 AM
RNS
Holding(s) in Company
07 May 2026 06:27 PM
RNS
Holding(s) in Company
01 May 2026 07:00 AM
RNS
PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29 Apr 2026 07:01 AM
RNS
Final Results
29 Apr 2026 07:00 AM
RNS
PRTC Voluntarily Delists Nasdaq Depositary Shares
27 Apr 2026 06:09 PM
RNS
Holding(s) in Company
27 Apr 2026 12:05 PM
RNS
PRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24 Apr 2026 05:58 PM
RNS
Holding(s) in Company
22 Apr 2026 12:00 PM
RNS
PRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16 Apr 2026 05:00 PM
RNS
Holding(s) in Company
16 Apr 2026 07:00 AM
RNS
Holding(s) in Company
13 Apr 2026 07:05 AM
RNS
Notice of Results
13 Apr 2026 07:00 AM
RNS
PRTC's Seaport Files for Proposed Nasdaq IPO
02 Apr 2026 01:12 PM
RNS
PRTC Publishes Phase 2b Deupirfenidone IPF Results
02 Apr 2026 12:03 PM
RNS
PRTC's Seaport: Positive Topline Ph1 for GlyphAgo
01 Apr 2026 07:00 AM
RNS
Total Voting Rights
25 Mar 2026 06:00 PM
RNS
PRTC’s Seaport: GlyphAllo Paper Published
13 Mar 2026 04:35 PM
RNS
PDMR Notification RSU Vesting
02 Mar 2026 07:00 AM
RNS
Total Voting Rights
25 Feb 2026 07:00 AM
RNS
PRTC to Present at Leerink Healthcare Conference
19 Feb 2026 05:15 PM
RNS
PRTC's Deupirfenidone Granted FDA & EU ODD for IPF
06 Jan 2026 12:00 PM
RNS
PureTech to Present at the JP Morgan Conference
18 Dec 2025 07:00 AM
RNS
PureTech Appoints Robert Lyne as CEO
10 Dec 2025 05:41 PM
RNS
Results of AGM on June 16, 2025 – Update Statement
10 Dec 2025 05:30 PM
RNS
Holding(s) in Company
08 Dec 2025 07:00 AM
RNS
PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
05 Dec 2025 06:00 PM
RNS
PRTC's Gallop: Positive Initial Topline AML Data
18 Nov 2025 05:30 PM
RNS
Holding(s) in Company
07 Nov 2025 06:18 PM
RNS
Holding(s) in Company
03 Nov 2025 02:00 PM
RNS
PRTC: New LYT-200 AML Data + Update at ASH
22 Oct 2025 07:00 AM
RNS
PRTC: New IPF Data Show Benefit in Older Patients
17 Oct 2025 05:30 PM
RNS
Holding(s) in Company
14 Oct 2025 07:00 AM
RNS
Holding(s) in Company
10 Oct 2025 05:59 PM
RNS
Holding(s) in Company
09 Oct 2025 06:10 PM
RNS
Holding(s) in Company
01 Oct 2025 07:00 AM
RNS
Holding(s) in Company
29 Sep 2025 07:00 AM
RNS
PRTC: New IPF Data Show Switch Patients Stabilized
24 Sep 2025 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
23 Sep 2025 05:30 PM
RNS
Holding(s) in Company
19 Sep 2025 05:52 PM
RNS
Holding(s) in Company
19 Sep 2025 07:00 AM
RNS
Holding(s) in Company
11 Sep 2025 12:05 PM
RNS
PRTC's Seaport Advances 2nd Candidate Into Clinic
04 Sep 2025 05:30 PM
RNS
Holding(s) in Company
01 Sep 2025 07:00 AM
RNS
Total Voting Rights
28 Aug 2025 07:00 AM
RNS
Half-year Report
21 Aug 2025 12:00 PM
RNS
PureTech Showcases Differentiated IPF Strategy
18 Aug 2025 07:00 AM
RNS
Notice of Results
13 Aug 2025 05:12 PM
RNS
PRTC's Vedanta Announces VE202 Phase 2 Results
12 Aug 2025 12:00 PM
RNS
PRTC Launches Celea to Advance Ph3-Ready IPF Drug

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings